Cell Source, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Cell Source, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2024 | Sep 30, 2024 | ($1.42M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2024 | ($1.49M) | Aug 19, 2024 |
| Q3 | 2024 | Jun 30, 2024 | ($1.49M) | Nov 14, 2024 |
| Q2 | 2024 | Mar 31, 2024 | ($1.28M) | Aug 19, 2024 |
| Q1 | 2024 | Mar 31, 2024 | ($1.28M) | Jul 29, 2024 |
| Q3 | 2024 | Mar 31, 2024 | ($1.28M) | Nov 14, 2024 |
| Q3 | 2024 | Sep 30, 2023 | ($1.34M) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($1.24M) | Aug 19, 2024 |
| Q3 | 2024 | Jun 30, 2023 | ($1.24M) | Nov 14, 2024 |
| Q3 | 2024 | Mar 31, 2023 | ($1.69M) | Nov 14, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.69M) | Jul 29, 2024 |
| Q2 | 2024 | Mar 31, 2023 | ($1.69M) | Aug 19, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.25M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($1.29M) | Sep 19, 2023 |
| Q3 | 2023 | Jun 30, 2022 | ($1.29M) | Nov 9, 2023 |
| Q3 | 2023 | Mar 31, 2022 | ($1.29M) | Nov 9, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($1.29M) | Aug 23, 2023 |
| Q2 | 2023 | Mar 31, 2022 | ($1.29M) | Sep 19, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($1.80M) | Dec 8, 2022 |
| Q3 | 2022 | Jun 30, 2021 | ($1.31M) | Dec 8, 2022 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2024 | Sep 30, 2024 | ($831.6K) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2024 | ($1.19M) | Aug 19, 2024 |
| Q1 | 2024 | Mar 31, 2024 | ($1.14M) | Jul 29, 2024 |
| Q3 | 2024 | Sep 30, 2023 | ($995.4K) | Nov 14, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($905.5K) | Aug 19, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($1.42M) | Jul 29, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($1.02M) | Nov 9, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($1.03M) | Sep 19, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($1.05M) | Aug 23, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($1.32M) | Dec 8, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($995.1K) | Dec 2, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($1.12M) | Nov 2, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($1.17M) | Nov 15, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($903.3K) | Aug 12, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($733.3K) | May 17, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($1.36M) | Nov 13, 2020 |
| Q2 | 2020 | Jun 30, 2019 | ($708.7K) | Aug 14, 2020 |
| Q1 | 2020 | Mar 31, 2019 | ($1.17M) | May 15, 2020 |
| Q3 | 2019 | Sep 30, 2018 | ($488.6K) | Nov 14, 2019 |
| Q2 | 2019 | Jun 30, 2018 | ($423.9K) | Aug 14, 2019 |